Trump tricks traders, but futures suggest ASX will turnaround on Monday

Published 05-OCT-2020 10:06 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The Trump news that triggered a substantial sell-off on the ASX on Friday, had a much more nominal impact on overseas markets on Friday night our time.

The S&P/ASX 200 index (XJO) shed 81 points on the day on Friday, but it was only in the last hour or so that the decline really accelerated with the index falling by about 62 points in that period.

On a week-on-week basis the close of 5792 points represented a decline of 173 points or nearly 3%, and it is worth noting that a break below 5784 points would have taken the XJO back to its worst close since mid-June.

If markets are right we should avoid further downside on Monday with the ASX SPI200 index up more than 1% or 67 points to 5853 points.

European markets were particularly resilient with the FTSE 100 gaining 22 points or 0.4% to close at 5902 points.

In France, the CAC 40 was relatively flat, while in Germany the DAX only gave up 0.3%, closing at 12,689 points.

While US markets felt the pinch more, it wasn’t a shockwave response with the Dow falling 0.5% to close at 27,682 points.

The NASDAQ was the main casualty, as it shed 251 points or 2.2% to close at 11,075 points.

To put this in perspective though, the index had rallied from about 11,000 points to 11,300 points throughout the week, and it could be argued that this was a bit of money taken off the table in the form of profit-taking.

Another key barometer of investor sentiment when there is a major event is the gold price.

There wasn’t a flock to gold – in fact, it finished slightly lower on the day at about US$1907 per ounce.

The last few days of the week weighed heavily on the oil price with the Brent Crude Oil Continuous Contract finishing at US$39.27 per barrel, down from US$43.00 per barrel on Monday.

In after-hours trading the commodity traded below the US$39.00 per barrel mark, a worrying sign as it hasn’t fallen below that level since June.

Elsewhere on the commodities front, copper reclaimed much of the lost ground from Thursday when it fell by more than 3% to US$2.90 per pound.

Nickel, zinc and lead all trended slightly lower.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X